Por: RTTNews Health October 11, 2022
Albireo Pharma, Inc. () announced Tuesday positive topline results from the Phase 3 ASSERT study evaluating the safety and efficacy of Bylvay in Alagille syndrome (ALGS) patients from birth to early adulthood.The global, double-blind, randomized, placebo-controlled trial met its primary endpoint of improvement in pruritus and its key secondary endpoint of reduction in serum bile acids (sBAs).There were no patient discontinuations and Bylvay was... + full article
Forbes USA Business October 13, 2022
This story appears in the October 2022 issue of Forbes Asia. Dilip SuranaCourtesy of Dilip Surana This story is part of Forbes’ coverage of India’s Richest 2022. See the full list . , the brothers who own generic drugs maker , saw their wealth rise 44% to $3.25 billion as... + más
Bay Leaf Authentic Indian Cuisine places priority on tradition and authenticity | The Advocate
Council Post: How Social Media Analytics Is Transforming Pharma Decision Making | Forbes
RTTNews USA Health October 03, 2022
Shares of Prometheus Biosciences Inc. () closed at an all-time high of $59.01 on Friday (Sep.30, 2022), reflecting a gain of over 100% in 3 months.Prometheus is a biotechnology company pioneering a precision medicine approach in developing novel therapeutic and companion... + más
Dodgers Dugout: Will the next Dodgers closer please stand up? | Los Angeles Times
Brayan Bello stumbles to cap promising rookie campaign and Red Sox again steamrolled by Blue Jays | The Boston Globe
Los Angeles Times USA Opinion October 02, 2022
If you’re a woman or person of color, your health is being hurt by a lack of diversity in healthcare. I suddenly realized that a few years ago at a conference for pharma executives. Dr. Lynn Seely, who was then the female chief executive officer of Myovant, a biopharmaceutical... + más
Council Post: How A Diverse Board Can Help Your Company | Forbes
Jody Rose and Jeff Bussgang are tackling tech’s diversity problem | The Boston Globe
Forbes USA Business September 30, 2022
, VP and Business Leader, Infovision Social—the Research, Digital Experience, Social Media Analytics arm of InfoVision. getty Social media has opened up a whole new dimension of insights for pharma companies. The conversations happening in social media are real-world... + más
Council Post: 10 Areas To Dedicate The Bulk Of Your Social Media Budget To (And Why) | Forbes
Cadence Brings Big Data And AI Analytics To SoC Verification | Forbes
NBC 6 South Florida USA World September 29, 2022
NBCUniversal Media, LLC What to Know Fall is here, which means that pumpkin spice is everywhere -- from food to drinks to home products. The distinctive blend even has its own day! (For those wondering, National Pumpkin Spice Day is Saturday.) However, despite the ubiquity of... + más
Pumpkin spice is the flavor of fall. But what is it? And where did it come from? | Chicago Sun Times
Jewelry company selling 'Pumpkin Spice Latte' ring | WGN-TV
Forbes USA Business September 24, 2022
Following another ugly market week, the average U.S. stock is now trading in Bear Market territory. Of course, such was also the case in 2020 and 2018 and 2016 and more than a few other periods throughout market history. Such is the hardship that must be endured to achieve... + más
What is storm surge, and what contributes to the deadly hurricane hazard? | CBS News
Early-adopter tax is in full force for the first batch of AM5 motherboards | Ars Technica
RTTNews USA Health September 24, 2022
Pacira BioSciences, Inc. () announced Wednesday positive topline results from its Phase 3 study of EXPAREL as a single-dose sciatic nerve block in the popliteal fossa for postsurgical regional analgesia in patients undergoing bunionectomy.EXPAREL achieved the study's... + más
Prometheus Hits New High | RTTNews
Placentas in COVID-positive pregnant women show injury with blood circulation and clotting | Chicago Tribune
About iurex | Privacy Policy | Disclaimer |